NVIDIA’s (NASDAQ: NVDA) stock price has risen more than 60% from its April low in early June and is likely to continue growing, potentially much higher due to the forces moving it.

Fundamental and technical factors aside, the rebound is assisting NVIDIA regain its position in terms of market cap and stock size, bringing another factor into play: FOMO. FOMO, or the fear of missing out, is the anxiety caused by thoughts that something might be happening that you could be missing.

In this instance, investors could be missing substantial capital gains and higher share prices. The potential for higher share prices is significant. Experts have been raising targets since the FQ1 earnings report, which has led to the high-end range, a move to $200 to $220, or about 20% at the consensus of $171 and nearly 60% at the top end.

A move to the top end could happen quickly, as news headlines accelerate a positive feedback loop in which higher prices underscore the gains that average businessmen are missing and the potential still present in the market.

NVIDIA’s News Cycle Fuels FOMO in June

Among those factors is the news cycle, not only is NVIDIA’s market cap getting attention, increasing general market anxiety, but the news cycle is robust. There has been a steady series of bullish news events since the Q1 release, including business advancement and analysts’ commentary.

The business advancements include plans to create a new supercomputer for the Department of Energy. Slated for 2026, it will be built on the next-generation Rubin platform and is expected to compress research time from years to days.

Other advancements are CoreWeave’s launch of what is now the largest, most powerful NVIDIA GPU cluster ever benchmarked, as well as the expected impact of the Stargate project. Experts at UBS see NVIDIA as the primary beneficiary of what was announced as a $500 billion project. The driver for NVIDIA will be the compute needs as OpenAI scales up. The benefit could top $25 billion, including networking and ancillary costs, depending on the total size and GPU/CPU mix. As it stands, the first Stargate data centre is forecasted to require 400,000 NVIDIA GB200 GPUs.

Upcoming catalysts for NVIDIA’s stock price are the expected launch of NVLink Fusion silicon for semi-custom AI infrastructure and the deal with Saudi Arabia’s HUMAIN. The NVLink Fusion system creates an ecosphere in which NVIDIA chips are linked with third-party CPUs and ASICs with the NVLink system. NVLink enables NVIDIA GPUs, CPUs, and ASICs to interconnect with each other, increasing efficiency and reducing latency typically found in other CPU and ASIC configurations.

Regarding HUMAIN, the deal is worth several hundred thousand NVIDIA Grace Blackwell GPUs and upcoming Rubin GPUs, including hardware and software to maximise their use. It has yet to reflect in the results or guidance, and is expected to inject billions into the results annually.

NVIDIA’s Stock Price Is Near a Critical Pivot Point

NVIDIA’s price action is rising in early June and approaching the critical pivot point of the all-time high. A move above or even to the all-time high would intensify FOMO in the market and likely lead to an influx of money. The influx could gain momentum and sustain an upward lift owing to the impact of indexing.

The S&P 500 and most indices and ETFs pegged to it are market-cap weighted, which means as NVIDIA’s stock price rises and its market capitalisation increases, its influence on the index will increase, and the indices and ETFs pegged to it will have to buy more to keep up.

The chart technicals are favourable. The rise in share prices is accompanied by bullish MACD, a bullish crossover in stochastic and the moving averages, which are pointing higher. The indication is for a retest of great resistance by early summer, with a chance of new highs in late June or early July. The risk is that resistance in the range of $150 will cap gains and keep this market in check until later in the year when subsequent earnings reports may offer a catalyst.

Where Should You Invest $1,000 Right Now?

Before you make your next trade, you’ll have to hear this.

MarketBeat keeps track of Wall Street’s most-rated and best-performing research analysts and the stocks they recommend to their clients on a daily basis.

Our team has identified the five stocks that top analysts are quietly whispering to their clients to purchase now before the broader market catches on… and none of the big-name stocks were on the list.

They believe these five stocks are the five best companies for investors to purchase now…